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Abstract 
Background: Venous access, a prerequisite for anesthesiological and surgical intervention in pediatric patients, is 
often difficult to establish and potentially painful. AV300 uses near infrared laser light to improve visibility of peripheral 
veins and could help cannulating them. The aim of this study was to examine if use of Accuvein® AV300 vein viewer 
could facilitate venous cannulation in children.
Methods: From January to March 2011, 238 consecutive pediatric patients (0–17 years) preceding surgical interven‑
tions were included. All participants including newborns, infants and children were allocated to groups [control group 
(124 patients) and intervention group (114 patients)] in a non‑random way. Randomization was not feasible because 
data was acquired retrospectively from a clinical quality management project. In control group, peripheral IV cannula‑
tion was performed without supporting device, in intervention group with support of AV300. Time and number of 
attempts until successful venous cannulation were defined as primary end points.
Results: Median time until successful cannulation was 2 min (range 0.1–20, quartiles: 25 %: 1; 75 %: 5) in the inter‑
vention group and 1 min (range 0.1–18, quartiles: 25 %: 0.2; 75 %: 2) in the control group (p < 0.01). Median number 
of attempts was higher in the intervention group (2; range 1–6, quartiles: 25 %: 1; 75 %: 3) than in the control group 
(1; range 1–6, quartiles: 25 %: 1; 75 %: 2, p < 0.01). Rate of cannulations successful at first attempt was 0.45 (51 of 114, 
95 % CI 0.35–0.54) in the intervention group and 0.73 (90 of 124, 95 % CI 0.65–0.81) in the control group (p < 0.01).
Conclusions: In our study we were not able to reduce neither time nor number of attempts until a successful venous 
cannulation in children using the vein viewer. Given certain limitations of our study as the lack of randomization and 
no control for inter‑operator variability, the conclusions drawn from it are also limited, but by our results laser‑sup‑
ported cannulation cannot be recommended for standard procedures.
Trial registration: ClinicalTrials.gov NCT01434537. Registered 29 July 2011
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Background
In many clinical situations a fast and effective venous 
access is essential for patient’s safety and care: for rehy-
dration, in emergency situations, application of systemic 
drugs and for every anesthesiological procedure. While 
inhalational anesthesia induction in children has been 
standard care throughout the world for many years, 
the prerequisite of a peripheral venous access prior to 
the induction becomes more and more part of clinical 
practice, at least in elective procedures. The aim is to 
establish the venous access fast, with few attempts and 
without causing pain in the pediatric patients. It has been 
shown that there are effective ways to reduce pain [1] by 
applying local anesthetics on the puncture site prior to 
puncture.
In many pediatric patients the venous access is difficult 
to establish due to their thicker layer of subcutaneous tis-
sue compared to adults, particularly in children younger 
than 3 years [2]. In these cases the prolonged procedure 
can result in more pain, trauma and subcutaneous hem-
orrhage from frequent attempts. For the latter, people 
tried to use different methods to dilate the subcutane-
ous vein to enhance visibility, and facilitate cannulation 
[3–5], and—more important—many viewing system were 
invented to facilitate the locating of superficial veins at a 
peripheral site [6–9]. The AccuVein® AV300 acts as one 
of the vein imaging techniques using near-infrared (NIR) 
light [9–13]. It is a portable, non-contact vein viewer 
for improving the detection of subcutaneous veins. NIR 
light emitted from the imaging system is used to locate 
the vein to be punctured. However, up to now and to 
our knowledge, few reports are available about its effects 
on subcutaneous vein cannulation in pediatric patients 
in a pre-operation setting. This trial aims to investigate 
whether the AV300 could reduce time until and number 
of attempts for successful peripheral vein cannulation in 
pediatric patients in a pre-operation setting.
Methods
The study was approved by the IRB of Charité 
(EA1/171/11) and registered at clinicalTrials.gov (ID: 
NCT01434537) on July 29th, 2011. The ethics commit-
tee waived the need for written informed consent for the 
intervention group, since this retrospective study was 
performed as an analysis of a project accompanying the 
introduction of an already approved device into clinical 
standard of our department. The project was initiated 
from the Department of Anesthesiology and Intensive 
Care CVK/CCM, Charité-Universitaetsmedizin Berlin, 
and not from the manufacturer of the device. No data 
were handed out to the manufacturer. Only because the 
project revealed information that seemed to be impor-
tant to publish, the ethics committee was asked whether 
to retrospectively analyze and publish the anonymous 
data and agreed to do so. From January 2011 altogether 
238 consecutive pediatric patients from 0 to 17  years 
of age preceding surgical interventions in the pediat-
ric operating room of the Campus Virchow-Klinikum, 
Charité-Universitaetsmedizin Berlin, were included 
in the trial. All of the participants including newborns, 
infants and children were allocated to two groups in 
two timeframes of each 4  weeks: The first consecutive 
114 patients were allocated to the intervention group, 
the next 124 into the control group. Randomization was 
not feasible because data was acquired retrospectively 
from a clinical quality management project. In the con-
trol group, peripheral IV cannulation was performed as 
usual without any supporting device. In the intervention 
group, the same intervention as in the control group was 
done but with support of AV300 vein viewer (AccuVein®, 
LLC, 40 Goose hill Rd, Cold Spring Harbour, NY) fol-
lowing the User Manual of AccuVein® model AV300 vein 
viewing system [13]. During IV insertion, the AV300 was 
held by an assistant perpendicularly about 18  cm over 
the patient’s limb where the vein was expected to be 
located. Sometimes, in order to get a good visualization 
of the target vein, the height or the angle of the device 
had to be slightly altered. The AV300 should not beam 
directly in the eyes because the device emits two Class 
2 lasers, a red one with the wavelength of 642  nm and 
a near-infrared one at 785  nm. Due to the absorption 
of the near-infrared light by hemoglobin, the vein can 
be visualized [13]. Before the start of this study doctors 
and nurses were trained for the use of the vein viewer by 
an anesthetist that was trained by the manufacturer. It 
is common practice in our clinic that everyone must be 
trained for every device before using it the first time on 
patients.
The catheters used for venous cannulation were BD 
Insyte Autoguard Winged 24GA from Becton–Dickin-
son Infusion Therapy Systems Inc., Sandy, Utah, USA; BD 
Neoflon 24GA and 26GA, BD Venflon Pro Safety 22GA 
from Becton–Dickinson Infusion Therapy AB, Helsing-
borg, Sweden.
All IV cannulations were performed by skilled and 
experienced anesthesiologists, residents and nurses. The 
time from the beginning of the first cannulation attempt 
(first skin-needle contact) was measured by a member of 
the research team. The end of the procedure was defined 
as the successful establishment of a vein access easily 
flushable by sterile 0.9 % sodium chloride solution.
Data were collected on gender, age, weight, presence 
of general anesthesia or not, received local anesthesia 
(EMLA®, a mixture of lidocaine and prilocaine) or not, 
needle size, the time and number of attempts until suc-
cessful cannulation for both groups.
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Data were analyzed by SPSS for windows version 18 
(SPSS Inc., Chicago, IL). Results were given by rates (in 
%) with 95 % confidence limits as well as by median and 
25–75  %-quartiles for continuous variables because of 
deviations from normal distribution. Chi square and 
nonparametric (Mann–Whitney) testing was used to 
access the differences in demographic data (gender, age, 
weight, received general anesthesia or not, received local 
anesthesia or not, needle size, first-attempt success rate) 
between both groups. Explorative data analysis including 
checks for normal distribution (P–P plots) was applied. 
Time and number of attempts until successful venous 
cannulation were defined as primary end points. Differ-
ences in outcome variables were analyzed by nonpara-
metric tests (Mann–Whitney-U-test). Rates were tested 
using the Chi square test. P-values <0.05 were considered 
statistically significant. All tests should be understood 
as constituting exploratory data analysis, such that no 
adjustments for multiple testing have been made.
Results
Basic characteristics: There were 238 pediatric patients 
involved in the trial, 124 in the control group, and 114 
in the intervention group. The youngest patient was 
<1  month; the oldest 17  years and 5  months old, mean 
age was 48.4 (median: 24)  months. Differences between 
both groups were tested with Chi square-test as well as 
Mann–Whitney-tests and there were no statistically sig-
nificant differences found in distribution of gender, age, 
weight and presence of general anesthesia. There were 
no differences found in the sizes of the used needles 
(p = 0.069). The only difference in this main group was 
that in the intervention group the proportion of patients 
with applied local anesthetics (EMLA®) was higher 
(p = 0.003) (Table 1).
Median time until successful venous cannulation was 
2  min (range 0.1–20, quartiles: 25  %: 1; 75  %: 5) in the 
intervention group and 1  min (range 0.1–18, quartiles: 
25 %: 0.2; 75 %: 2) in the control group (p < 0.01) (Fig. 1).
Median number of attempts was higher in the inter-
vention group (2; range 1–6, quartiles: 25 %: 1; 75 %: 3) 
than in the control group (1; range 1–6, quartiles: 25 %: 1; 
75 %: 2, p < 0.01) (Fig. 2). The rate of cannulation which 
were successful after the first attempt was 0.45 (51 of 114, 
95 % CI 0.35–0.54) in the intervention group and 0.73 (90 
of 124, 95 % CI 0.65–0.81) in the control group (p < 0.01).
If the subgroup of 171 patients of 72  months and 
younger is regarded, there was no difference in the use 
of EMLA® between the two groups. In this subgroup 
median time until cannulation was 1 min (range 0.1–18, 
quartiles: 25 %: 1; 75 %: 2) in the control and 2 min (0.1–
20, quartiles: 25 %:1; 75 %: 6) in the experimental group 
(p < 0.01) (Fig. 3). The median number of attempts was 
higher in the intervention group (2, range 1–6, quartiles: 
25 %: 1; 75 %: 4) than in the control group (1, range 1–6, 
quartiles: 25 %: 1; 75 %: 2; p < 0.01) (Fig. 4). The rate of 
cannulation which were successful after the first attempt 
was 0.38 (32 of 85, 95 % CI 0.27–0.48) in the intervention 
group and 0.66 (57 of 86, 95 % CI 0.56–0.76) in the con-
trol group (p < 0.01).
Discussion
The results of this trial indicate that in our study group 
use of the Accuvein® AV300 vein scanner was not able to 
Table 1 Basic characteristics
IQR interquartile range, GA Gauge, LA local anesthetic, EMLA® Eutectic Mixture of 
Local Anesthetics
Control group  
count (% within  
groups) or  
median (IQR),  
n = 124
Intervention 
group count (% 




 Male 72 (58.1) 59 (51.8) p = 0.362
 Female 52 (41.9) 55 (48.2)
Age (months)
 0–3 12 (9.7) 19 (16.7) p = 0.346
 4–12 24 (19.4) 28 (24.6)
 13–24 22 (17.7) 15 (13.2)
 25–72 28 (22.6) 23 (20.2)
 ≥73 38 (30.6) 29 (25.4)
Weight (kg)
 <5 9 (7.3) 11 (9.6) p = 0.538
 5–9.99 37 (29.8) 41 (36.0)
 10–19.99 38 (30.6) 29 (25.4)
 20–39.99 24 (19.4) 24 (21.1)
 ≥40 16 (12.9) 9 (7.9)
General anaesthetic (sevoflurane or N2O)
 No 52 (41.9) 41 (36.0) p = 0.356
 Yes 72 (58.1) 73 (64.0)
Local anaesthetic (EMLA®)
 No 67 (54.0) 39 (34.2) p = 0.003
 Yes 57 (46.0) 75 (65.8)
LA in >72 months
 No 28 (73.7) 6 (20.7) p < 0.001
 Yes 10 (26.3) 23 (79.3)
LA in ≤72 months
 No 39 (45.3) 33 (38.8) p = 0.440 
 Yes 47 (54.7) 52 (61.2)
Size of needles (GA)
 26 0 (0) 3 (2.6) p = 0.069
 24 59 (47.6) 63 (55.3)
 22 57 (46.0) 38 (33.3)
 20 8 (6.5) 10 (8.8)
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reduce neither the time needed for establishing a periph-
eral venous access nor the needed number of puncturing 
attempts.
Our findings are comparable to those of a trial exam-
ining a similar device in an emergency room setting 
where the use of the vein viewer could not facilitate the 
venipuncture either [14]. Though another study group 
found that in a similar setting the use of such a device 
may decrease time of venous cannulation in children age 
0–2 years [15].
These results differ substantially from a recent study 
showing that a vein viewing system similar to the 
device used in our study was able to facilitate venous 
cannulation of peripheral veins in difficult veins [16]. A 
study with a randomized-controlled design on another 
non-contact vein viewing system using the technique of 
transillumination reported a good visibility of peripheral 
veins, higher success rates at the initial attempt and less 
time taken until successful peripheral venous cannulation 
[7].
The use of local anesthetics like EMLA® might have an 
influence on the results of these studies as it was reported 
that EMLA® could cause vasoconstriction of the periph-
eral veins and pallor or edema at the application site and 
therefore make vein cannulation more difficult [17, 18]. 
Though one investigation indicated the skin-related side 
effects of EMLA® were mild and transient, and might not 
Fig. 1 Time until successful venous cannulation (CON control; EXP 
experimental group)
Fig. 2 Number of attempts until succesful venous cannulation (CON 
control; EXP experimental group)
Fig. 3 Time until successful venous cannulation in subgroup up to 
72 months (CON control; EXP experimental group)
Fig. 4 Number of attempts until succesful venous cannulation in 
subgroup up to 72 months (CON control; EXP experimental group)
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have an influence on vein cannulation [19], EMLA® is 
still thought to be one of the potential confounders in our 
trial. In our study our results seemed to point in the same 
direction, with EMLA® being in a higher proportion in 
the intervention group, but when analyzing a subgroup of 
children of 72 months and younger there was no signifi-
cant difference in the use of EMLA® (Table  1). Neither 
in this group without the EMLA® difference, the use of 
the AccuVein® AV300 was able to reduce neither the time 
nor the number of attempts until successful cannulation 
of peripheral veins either.
Another product designed on the basis of NIR (Vein-
Viewer®, Luminetx Corporation, Memphis, Tenn.), pre-
sented prominent value in facilitating venipuncture and 
IV catheterization [9, 20, 21]. A clinical observation 
reported a high rate of satisfaction from fifty question-
naires was but there was no control group [20]. Another 
investigator argued in a recent publication that no ben-
efit was shown for the first-attempt success rate during 
the pediatric IV cannulation with aid of VeinViewer® 
in a randomized controlled trial [14]. Recently Szmuk 
et  al. reported that the use of the same device could 
even worsen the first-attempt cannulation rate in a rand-
omized trial [22].
In our study, errors in size and position between the 
vein shadow and the vein itself may have contributed 
to the outcome. In some cases, it was difficult to get an 
IV insertion due to the enlarged vein images with aid of 
the AV300; meanwhile, a failing detection of the target 
vein depth was thought to be an obvious disadvantage. 
In addition, the target site chosen for IV insertion was 
just exposed in the NIR beam and punctured directly, 
often leading to deformation of the vessel image by the 
needle pressing. So the endeavor to avoid the deforma-
tion of the vein image would offer one of the solutions to 
improve the first-attempt success rate as using the NIR 
devices [20]. A recent study found that a similar device 
could facilitate the venous access in difficult cases [16]. A 
recently published cluster randomized trial came to the 
conclusion that even if vein visibility was enhanced, near-
infrared devices do not improve cannulation [23].
The main limitation of our trial is the lack of randomi-
zation which causes a bias. The sample size was large 
compared to similar studies but might have still been too 
small. The influence of the person practicing the veni-
puncture was limited by the fact that only experienced 
persons were in charge but this fact could be controlled 
better by stratifying the staff or switching after the half of 
the study into the other group. Observer bias could have 
been caused by the fact that the member of the research 
team measuring the time until successful cannulation was 
not blinded. A dummy vein viewer would need to have 
been used in the control group to control for. The comor-
bidities and ASA classification of the patients should also 
be taken into account in a future study to clarify the ben-
efit and utility of these devices based on NIR.
Conclusions
In our study the use of the Accuvein® Vein Viewer was 
not able to reduce neither time nor number of attempts 
until a successful venous cannulation. Thus, its use in 
standard procedures with easy cannulations cannot be 
recommended within the limitations of this study.
Even if the findings of these studies including the pre-
sent examining the benefit of vein viewing systems are 
inconsistent, there might be a place for using them in 
cases where peripheral veins are poorly visible or inexpe-
rienced medical staff performs the cannulation.
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